Cipla has received an approval for its product Q-TIB from World Health Organisation (WHO).
Cipla has received an approval for its product Q-TIB from World Health Organisation(WHO). Q-TIB is a novel fixed dose combination in a single tablet. This is the first time that such a combination has been made available in the world. Cipla will market the product globallySource : BSE
Read More
